Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than addressing the merits of the case.
Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than addressing the merits of the case.